Winnie Weng

A Quantitative Framework to Evaluate Proarrhythmic Risk in a First‐in‐Human Study to Support Waiver of a Thorough QT Study

CH Nelson, Lijing Wang, Winnie Weng et al. · Clinical Pharmacology & Therapeutics · 2015 · 28 citations

Medicine, Cardiology, Pharmacology +17

Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal Impairment

Yan Xin, Jun Kawashima, Winnie Weng et al. · The Journal of Clinical Pharmacology · 2017 · 17 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Phase 1 First‐in‐Human, Single‐ and Multiple‐Ascending Dose, and Food Effect Studies to Assess the Safety, Tolerability, and Pharmacokinetics of Presatovir for the Treatment of Respiratory Syncytial Virus Infection

Polina German, Yan Xin, Jason W. Chien et al. · The Journal of Clinical Pharmacology · 2018 · 15 citations

Medicine, Infectious Diseases, Pharmacology +10

Lack of Drug‐Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy Volunteers

Rebecca Begley, Kacey Anderson, Timothy R. Watkins et al. · Clinical Pharmacology in Drug Development · 2020 · 14 citations

Medicine, Pharmacokinetics, Pharmacology +14